Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia

Irene Homminga, Rob Pieters, Anton W. Langerak, Johan J. de Rooi, Andrew Stubbs, Monique Verstegen, Maartje Vuerhard, Jessica Buijs-Gladdines, Clarissa Kooi, Petra Klous, Pieter van Vlierberghe, Adolfo A. Ferrando, Jean Michel Cayuela, Brenda Verhaaf, H. Berna Beverloo, Martin Horstmann, Valerie de Haas, Anna-Sophia Wiekmeijer, Karin Pike-Overzet, Frank J. T. StaalWouter de Laat, Jean Soulier, Francois Sigaux, Jules P. P. Meijerink*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

318 Citations (Scopus)

Abstract

To identify oncogenic pathways in T cell acute lymphoblastic leukemia (T-ALL), we combined expression profiling of 117 pediatric patient samples and detailed molecular-cytogenetic analyses including the Chromosome Conformation Capture on Chip (4C) method. Two T-ALL subtypes were identified that lacked rearrangements of known oncogenes. One subtype associated with cortical arrest, expression of cell cycle genes, and ectopic NKX2-1 or NKX2-2 expression for which rearrangements were identified. The second subtype associated with immature T cell development and high expression of the MEF2C transcription factor as consequence of rearrangements of MEF2C, transcription factors that target MEF2C, or MEF2C-associated cofactors. We propose NKX2-1, NKX2-2, and MEF2C as T-ALL oncogenes that are activated by various rearrangements.

Original languageEnglish
Pages (from-to)484-497
Number of pages14
JournalCancer cell
Volume19
Issue number4
DOIs
Publication statusPublished - 12-Apr-2011
Externally publishedYes

Keywords

  • GENE-EXPRESSION
  • ACTIVATION MECHANISM
  • HOMEOBOX GENE
  • TARGET GENE
  • C-MYC
  • FUSION
  • CANCER
  • NOTCH1
  • IDENTIFICATION
  • TRANSFORMATION

Fingerprint

Dive into the research topics of 'Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia'. Together they form a unique fingerprint.

Cite this